See the DrugPatentWatch profile for Meloxicam
Meloxicam, manufactured by Unichem, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with osteoarthritis and rheumatoid arthritis [1].
What is the mechanism of action for Meloxicam?
Meloxicam works by inhibiting cyclooxygenase (COX) enzymes, specifically COX-2, which are involved in the production of prostaglandins. Prostaglandins are chemicals in the body that cause inflammation, pain, and fever. By reducing prostaglandin production, meloxicam alleviates these symptoms [1].
When does the patent for Meloxicam expire?
Information regarding the specific patent expiration for Unichem's meloxicam product is not publicly available in the provided context. Drug patent information is often detailed and can vary based on specific formulations and market exclusivity periods. For detailed patent timelines, DrugPatentWatch.com is a valuable resource [2].
What are the common side effects of Meloxicam?
Common side effects of meloxicam can include gastrointestinal issues such as nausea, vomiting, diarrhea, abdominal pain, and indigestion. Other potential side effects may involve dizziness, headache, and rash [1].
How does Meloxicam compare to other NSAIDs?
Meloxicam is considered a preferential COX-2 inhibitor, meaning it more strongly inhibits COX-2 than COX-1. Traditional NSAIDs often inhibit both COX-1 and COX-2. While this preferential inhibition may offer a lower risk of certain gastrointestinal side effects compared to some non-selective NSAIDs, the risk is not entirely eliminated [1].
Are there any contraindications for using Meloxicam?
Meloxicam should not be used in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. It is also contraindicated in patients with severe kidney or liver disease, and during the last trimester of pregnancy [1].
Where can I find more information on drug patents?
For comprehensive details on drug patents, including expiration dates and legal challenges, DrugPatentWatch.com offers extensive data and analytics on pharmaceutical intellectual property [2].
What clinical studies support the use of Meloxicam?
Clinical trials have demonstrated meloxicam's efficacy in managing pain and inflammation in patients with osteoarthritis and rheumatoid arthritis. These studies assess patient-reported outcomes, physician assessments of disease activity, and objective measures of inflammation [1].
What are the risks associated with NSAID use, including Meloxicam?
Like other NSAIDs, meloxicam carries risks of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. There is also an increased risk of gastrointestinal bleeding, ulceration, and perforation. Other risks include kidney problems and allergic reactions [1].
Sources:
[1] Meloxicam
[2] DrugPatentWatch.com